Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penson

Showing results (331-340 of 1,177) with videos related to

Pageof 118
Sort By:
Reviews in Urology|September 30, 2017
A discussion on the AUA castrateresistant prostate cancer guidelinesDavid M Albala, David F Penson
Seminars in Oncology|April 1, 2009
Ovarian stromal and germ cell tumorsCarolyn R Koulouris, Richard T Penson
BJU International|June 18, 2010
Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gapDaniel A Barocas, David F Penson
European Journal of Pharmacology|April 6, 2006
Effects of hypoxia on the vasodilator activity of nifedipine and evidence of secondary pharmacological propertiesKenneth J Broadley, Peter E Penson
Pharmacological Research|November 7, 2016
D-003 (Saccharum officinarum): The forgotten lipid-lowering agentKamal Awad, Peter Penson, Maciej Banach
Cancer Investigation|February 9, 2008
Internet health resources and the cancer patientGeorge J Huang, David F Penson
Urologic Oncology|July 17, 2012
Systemic therapy and the urologic oncologist: a unique opportunity for the specialty to provide comprehensive care that ultimately benefits the patientDavid F Penson, Paul H Lange
Urologic Oncology|July 24, 2012
The Patient Protection and Affordable Care Act: the impact on urologic cancer careKirk A Keegan, David F Penson
Autonomic & Autacoid Pharmacology|December 15, 2004
The roles of alpha- and beta-adrenoceptor stimulation in myocardial ischaemiaK J Broadley, P E Penson
European Urology Focus|May 11, 2019
Functional Recovery Following Primary Treatment for Prostate Cancer: Update from the CEASAR StudyDaniel A Barocas, David F Penson,
Pageof 118

Showing results (331-340 of 1,177) with videos related to

Sort By:
Pageof 118
Reviews in Urology|September 30, 2017
A discussion on the AUA castrateresistant prostate cancer guidelinesDavid M Albala, David F Penson
Seminars in Oncology|April 1, 2009
Ovarian stromal and germ cell tumorsCarolyn R Koulouris, Richard T Penson
BJU International|June 18, 2010
Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gapDaniel A Barocas, David F Penson
European Journal of Pharmacology|April 6, 2006
Effects of hypoxia on the vasodilator activity of nifedipine and evidence of secondary pharmacological propertiesKenneth J Broadley, Peter E Penson
Pharmacological Research|November 7, 2016
D-003 (Saccharum officinarum): The forgotten lipid-lowering agentKamal Awad, Peter Penson, Maciej Banach
Cancer Investigation|February 9, 2008
Internet health resources and the cancer patientGeorge J Huang, David F Penson
Urologic Oncology|July 17, 2012
Systemic therapy and the urologic oncologist: a unique opportunity for the specialty to provide comprehensive care that ultimately benefits the patientDavid F Penson, Paul H Lange
Urologic Oncology|July 24, 2012
The Patient Protection and Affordable Care Act: the impact on urologic cancer careKirk A Keegan, David F Penson
Autonomic & Autacoid Pharmacology|December 15, 2004
The roles of alpha- and beta-adrenoceptor stimulation in myocardial ischaemiaK J Broadley, P E Penson
European Urology Focus|May 11, 2019
Functional Recovery Following Primary Treatment for Prostate Cancer: Update from the CEASAR StudyDaniel A Barocas, David F Penson,
Pageof 118